dehaze raises €3.2M for AI chronic disease detection
Tech.eu / 4/28/2026
📰 NewsIndustry & Market MovesModels & Research
Key Points
- dehaze, a Munich-based healthtech AI company, raised €3.2M in seed funding to expand its AI platform for chronic disease detection.
- The investment is intended to meet rising international demand by growing dehaze’s engineering, research, and commercial teams.
- The funding will also accelerate product development as the company scales its AI capabilities in the chronic disease detection space.
- The seed round was led by YZR Capital and DN Capital, with participation from Angel Invest, Zoho, and Better Ventures.
dehaze, a Munich-based healthtech AI company, hasraised €3.2 million in a seed funding round led by YZR Capital and DN Capital,with participation from Angel Invest, Zoho, and Better Ventures. The fund...
Continue reading this article on the original site.
Read original →Related Articles
Black Hat USA
AI Business
Big Tech firms are accelerating AI investments and integration, while regulators and companies focus on safety and responsible adoption.
Dev.to
Claude Haiku for Low-Cost AI Inference: Patterns from a Horse Racing Prediction System
Dev.to
How We Built an Ambient AI Clinical Documentation Pipeline (and Saved Doctors 8+ Hours a Week)
Dev.to
🦀 PicoClaw Deep Dive — A Field Guide to Building an Ultra-Light AI Agent in Go 🐹
Dev.to
